دانلودمقاله باموضوع سارکوپنی و ضعف
در قالب pdf و در 11 اسلاید،قابل ویرایش، شامل:
موضوع به انگلیسی:Sarcopenia and Frailty
بخشی از متن:Sarcopenia and frailty are prevalent in the chronic kidney disease (CKD) population. Sarcopenia is characterised
by the loss of muscle mass and function, while frailty is defined as a multi-system impairment
associated with increased vulnerability to stressors. There is substantial overlap between the 2 conditions,
particularly with regards to physical aspects: low grip strength, gait speed and low muscle mass. Both
sarcopenia and frailty have been associated with a wide range of adverse health outcomes. Although there
is no recommended pharmacological treatment as yet, it is widely accepted that exercise training and
nutritional supplementation are the key interventions to maintain skeletal muscle mass and strength. This
review aims to present a comprehensive overview of sarcopenia and frailty in patients with CKD.
